Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

Center for Universal Access and Disability Support (CUADS) produces 22 graduates
2016-04-26

Description: Lutho Xintolo and mom Tags: Lutho Xintolo and mom

Lutho Xintolo (right) is one of the Centre for Universal Access and Disability Support 2016 graduates. She is currently pursuing her Honours in Psychology.
Photo: Supplied

Once again, the University of the Free State (UFS) hosted a successful series of graduations from 12-15 April 2016 where 3681 students were conferred qualifications at the Bloemfontein Campus. Among those graduating were 22 students who are affiliated with the university’s Center for Universal Access and Disability Support (CUADS).

Some of these students included Zingisa Ngwenya, who is currently busy with her second degree; Grant Lombaard, Zanele Morerwa, and Lutho Xintolo, all of whom are pursuing their Honours degrees. Louzanne Coetzee, a visually-impaired international champion athlete, was awarded a Communication: Corporate Marketing Honours degree this autumn. “We have five athletes and a cyclist with disabilities, amongst our students who are of world-class standard,” said Martie Miranda, Head of the Center.

The Center assists students to gain access to study courses, buildings, and lecture venues, learning material such as Braille, audio, enlarged print, and E-text, computer facilities with assistive technology and software and adapted hardware, and a specialised examination and test venue for alternative test and exam procedures,” Miranda added.

Students with disabilities who enrol with CUADS receive support according to their individual needs from registration through to graduation.  “During this process we identify challenges experienced in their administrative, academic, support, student life, and physical environments, and then address these challenges,” Miranda said.

Support provided by the Center includes amanuenses and extra time during tests and exams according to the student’s specific needs, (as determined through evaluation by the Extra Time Panel), together with Student Counselling and Development, academic tutors provided by the New Academic Tutor programme in collaboration with the UFS Centre for Teaching and Learning, and Sign Language interpreters or lip-speakers as well as real-time captioning.

Students with specific learning difficulties, mobility, visual, or hearing impairments, psychological, or other chronic conditions that might have a disabling effect on them, as well as those with temporary impairments, are fully supported by the CUADS. The Center strives to ensure that students achieve their full potential throughout their journey with our university.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept